DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $29.50 Consensus Target Price from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have received an average recommendation of "Hold" from the nine ratings firms that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $29.50.

A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, November 8th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday. Leerink Partners downgraded DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research report on Thursday, November 7th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently made changes to their positions in the business. Scientech Research LLC bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $846,000. Lazard Asset Management LLC lifted its position in shares of DENTSPLY SIRONA by 3.2% in the 1st quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier's stock worth $135,440,000 after purchasing an additional 126,351 shares during the period. VELA Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $2,168,000. M&G Plc purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at about $8,817,000. Finally, Virtu Financial LLC bought a new position in DENTSPLY SIRONA in the first quarter worth about $1,027,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Trading Down 1.9 %

Shares of XRAY stock opened at $18.52 on Thursday. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a 50 day moving average of $23.54 and a 200-day moving average of $25.20.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 EPS. As a group, analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.